Today's innovators in health care and their financers increasingly need solutions:

o   For faster product development and commercialization

o   To meet demanding regulatory requirements

o   To efficiently build value by limiting time and capital consumption

o   For penetrating change-resistant markets

o   To provide investors with financial return by making meaningful innovations available to patients

Return On Science Ventures is designed to offer such solutions:
Productivity: more scientific inventions are successfully turned into important medical innovations;
Efficiency: ventures consume less time and money by uninterrupted and focused development of their innovations;

Lower development costs, longer effective patent life, improved competitiveness drive up exit values and returns.

ROSV is a new investment firm based on Innovating Venture Capital, a revolutionary investment model for sustainable results.

Return On Science Ventures: -   offers capital investments integrated with guidance -    exploits scientific inventions with expertise in  product and business development --   maintains an Integrated Development Network -   co-invests without a carried interest -   does not charge a fee but budgets transparently -   operates under independent supervision

Innovating Venture Capital: -  shortens the investment cycle in life sciences -   removes the financing risk for ventures --   reduces the product development risk for ventures --   manages the technological risk for ventures -   makes innovation and value creation continuous and sustainable -   offers liquidity

 

Innovating Life Science companies are an attractive sector for long term investors seeking high, reliable return on investments. Financial return goes hand in hand with the societal benefits of better and more affordable health care.

o   Long term, rising demand worldwide for medical products that provide better and more affordable care.

o   High return on successful innovation balances high risk and time consuming product development.

o   Excellent opportunities for improving returns by:
(1) increasing productivity of innovation processes, and
(2) improving efficiency of product development.

o   Abundant sources of innovation exist: small innovating companies, startups with expertise, vision and motivation to transform scientific inventions into innovative products that fulfill unmet medical needs.

o   Many startups perish in the Valley of Death due to lack of know-how in product development, business management and commerce, in deadly embrace with short acting financial resources. Traditional VC cannot help startups through this difficult phase due to its investment model and methods. The sustainable solution is: prevent the Valley of Death by using the Innovating Venture Capital model and methods of ROSV.

ROSV can offer investors higher and reliable returns than usual in the industry. Innovating Venture Capital requires shifts in thinking and in methods to truly align all stakeholders:

o   Reward of the ROSV fund manager is based on the return of the fund, and is independent from the fund size. As a co-investor, the fund manager equally benefits from low fund costs, optimal risk management and returns.

o   The business opportunity per venture is leading the investment policy of ROSV. Optimal return for investors and entrepreneurs will be pursued at any time, because the fund's run time and stage don't play any role.

o   ROSV invests capital and expertise tailored to the ventures' business cycles and in a sustainable way. It builds value from true medical innovation instead of from time-dependent fluctuations in valuations, which are notoriously difficult to predict.

o   Risk is limited by spreading investments over time and sectors. For each individual venture risk is controlled by assuring the venture has access to the right expertise at the right time.

ROSV seeks visionary investors who:

o   Deem that the importance of medical innovation for health care is the right investment for their capital and time, provided they can rely on return on investment;

o   Are interested in a constant flow of returns more than in a single success;

o   Understand that investing long term will actually increase the speed of innovation and achieving significant returns;

o   Agree with the importance of sustainable, business cycle driven investing to prevent the loss of time and value caused by start-stop financing;

o   Can contact ROSV: Taco van der Feltz on tvanderfeltz@returnonscience.biz